CytoDyn (CYDY) Enterprise Value Growth (1y) (2011 - 2026)
CytoDyn (CYDY) Enterprise Value Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | CytoDyn | 267.79 Mn | 267.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 4.54% |
| Nov 30, 2025 | 76.65% |
| Aug 31, 2025 | 62.55% |
| May 31, 2025 | -77.55% |
| Feb 28, 2025 | -1,068.09% |
| Nov 30, 2024 | -14,413.61% |
| Aug 31, 2024 | -281.17% |
| May 31, 2024 | -163.83% |
| Feb 29, 2024 | 72.54% |
| Nov 30, 2023 | 26.50% |
| Aug 31, 2023 | -39.82% |
| May 31, 2023 | 39.94% |
| Feb 28, 2023 | -411.20% |
| Nov 30, 2022 | 97.75% |
| Aug 31, 2022 | 28.42% |
| May 31, 2022 | 87.53% |
| Feb 28, 2022 | 93.00% |
| Nov 30, 2021 | 69.82% |
| Aug 31, 2021 | -25,026.92% |
| May 31, 2021 | -137.50% |